Literature DB >> 30850056

Quantitative analysis of USP activity in vitro.

Shreya Dharadhar1, Robbert Q Kim1, Michael Uckelmann1, Titia K Sixma2.   

Abstract

Ubiquitin-specific proteases (USPs) are an important class of deubiquitinating enzymes (DUBs) that carry out critical roles in cellular physiology and are regulated at multiple levels. Quantitative characterization of USP activity is crucial for mechanistic understanding of USP function and regulation. This requires kinetic analysis using in vitro activity assays on minimal and natural substrates with purified proteins. In this chapter we give advice for efficient design of USP constructs and their optimal expression, followed by a series of purification strategies. We then present protocols for studying USP activity quantitatively on minimal and more natural substrates, and we discuss how to include possible regulatory elements such as internal USP domains or external interacting proteins. Lastly, we examine different binding assays for studying USP interactions and discuss how these can be included in full kinetic analyses.
© 2019 Elsevier Inc. All rights reserved.

Keywords:  Deubiquitinating enzymes; Protein purification; Protein–protein interaction; Quantitative enzymatic activity studies; Ubiquitin; Ubiquitin-specific protease

Mesh:

Substances:

Year:  2019        PMID: 30850056     DOI: 10.1016/bs.mie.2018.12.023

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  2 in total

1.  Biochemical characterization of TRIM72 E3 ligase and its interaction with the insulin receptor substrate 1.

Authors:  Ishita Gupta; Shreya Dharadhar; Titia Sixma; Sameena Khan
Journal:  Biochem Biophys Rep       Date:  2020-01-18

2.  Strategy for Development of Site-Specific Ubiquitin Antibodies.

Authors:  Ila van Kruijsbergen; Monique P C Mulder; Michael Uckelmann; Tibor van Welsem; John de Widt; Aldo Spanjaard; Heinz Jacobs; Farid El Oualid; Huib Ovaa; Fred van Leeuwen
Journal:  Front Chem       Date:  2020-02-21       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.